Structure-Activity Relationships of Synthetic Cathinones
Until recently, there was rather little interest in the structure-activity relationships (SARs) of cathinone analogs because so few agents were available and because they represented a relatively minor drug abuse problem. Most of the early SAR was formulated on the basis of behavioral (e.g., locomotor and drug discrimination) studies using rodents. With the emergence on the clandestine market in the last few years of a large number of new cathinone analogs, termed “synthetic cathinones”, and the realization that they likely act at dopamine, norepinephrine, and/or serotonin transporters as releasing agents (i.e., as substrates) or reuptake inhibitors (i.e., as transport blockers), it has now become possible to better examine their SAR and even their quantitative SAR (QSAR), in a more effective and systematic manner. An SAR picture is beginning to emerge, and key structural features, such as the nature of the terminal amine, the size of the α-substituent, stereochemistry, and the presence and position of aromatic substituents, are being found to impact action (i.e., as releasing agents or reuptake inhibitors) and transporter selectivity.
KeywordsDAT Methcathinone Monoamine transporters NET QSAR SAR SERT
Work from the authors’ laboratory was supported by US Public Health Services grants DA-01642 and DA-033930.
- 2.UNODC (2013) The challenge of new psychoactive substances. United Nations Office of Drugs and Crime, ViennaGoogle Scholar
- 3.EMCDDA (2015) European Drug Report. Trends and Developments. European Monitoring Centre for Drugs and Drug Addiction. LuxembourgGoogle Scholar
- 5.Glennon RA, Showalter D (1981) The effect of cathinone and several related derivatives on locomotor activity. Res Commun Subst Abus 2:186–192Google Scholar
- 26.Iversen LE (2010) Consideration of the cathinones. Advisory Council on the Misuse of Drugs. A report submitted to the Home Secretary of the UK (March 31, 2010)Google Scholar
- 40.Kolanos R, Cameron KN, Vekariya RH et al (2011) “Bath salts”: an imitation of methamphetamine plus cocaine? Abstract #249. Southeast Regional American Chemical Society Meeting. Richmond, VAGoogle Scholar
- 43.Del Bello F, Sakloth F, Partilla JS, et al. (2015) Ethylenedioxy homologs of N-methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: interactions with transporters for serotonin, dopamine, and norepinephrine. Bioorg Med Chem 23:5574–5579CrossRefGoogle Scholar
- 48.Sakloth F (2015) Psychoactive synthetic cathinones (or ‘bath salts’): investigation of mechanisms of action. PhD dissertation, Virginia Commonwealth University, Richmond, VAGoogle Scholar
- 53.Negus SS, Mello NK, Blough BE, et al. (2007) Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate “agonist” medications for cocaine dependence: studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys. J Pharmacol Exp Ther 320:627–636CrossRefGoogle Scholar
Open Access This chapter is licensed under the terms of the Creative Commons Attribution-NonCommercial 2.5 International License (http://creativecommons.org/licenses/by-nc/2.5/), which permits any noncommercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.
The images or other third party material in this chapter are included in the chapter's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the chapter's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.